Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function

International Journal of Neuropsychopharmacology

Volumn 16, Issue 7, 2013, Pages 1599-1609

  Vinish, Monika ^a   Elnabawi, Ahmed ^a   Milstein, Jean A ^a   Burke, Jesse S ^b   Kallevang, Jonathan K ^b   Turek, Kevin C ^b   Lansink, Carien S ^a   Merchenthaler, Istvan ^a   Bailey, Aileen M ^b   Kolb, Bryan ^c   Cheer, Joseph F ^a   Frost, Douglas O ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b ST MARY'S COLLEGE OF MARYLAND   (United States)

^c UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Amphetamine; atypical antipsychotic; conditioned place preference; dopamine; reward system

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMPHETAMINE; DOPAMINE 2 RECEPTOR; OLANZAPINE;

ADOLESCENT BEHAVIOR; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; COMPARATIVE STUDY; CONDITIONING; CONTROLLED STUDY; ELECTROSTIMULATION; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REWARD; STIMULATION; VENTRAL TEGMENTUM;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BENZAMIDES; BENZAZEPINES; BENZODIAZEPINES; BODY WEIGHT; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE ANTAGONISTS; FOLLOW-UP STUDIES; MALE; NUCLEUS ACCUMBENS; PROTEIN BINDING; RATS; RATS, LONG-EVANS; REWARD; SEROTONIN UPTAKE INHIBITORS; TRITIUM;

EID: 84880568781     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712001642     Document Type: Article

References (72)

1. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS (2011) Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf 20:177-184.
2. Andersen SL, Navalta CP (2011) Annual research review: new frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention? J Child Psychol Psychiatry 52:476-503.
3. Andersen SL, Rutstein M, Benzo JM, Hostetter JC, Teicher MH (1997) Sex differences in dopamine receptor overproduction and elimination. Neuroreport 8 :1495-1498.
4. Andersen SL, Thompson AT, Rutstein M, Hostetter JC, Teicher MH (2000) Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 37:167-169.
5. Aragona BJ, Day JJ, Roitman MF, Cleaveland NA, Wightman RM, Carelli RM (2009) Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats. Eur J Neurosci 30:1889-1899.
6. Azmitia EC (2001) Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56:413-424.
7. Baldessarini RJ, Tarazi FI (2001) Drugs and the treatment of psychiatric disorders : psychosis and mania. In : Goodman & Gilman's The pharmacological basis of therapeutics, 10th edn (Hardman JG, Limbird LE, Gilman AG, eds), pp. 485-520. New York: McGraw Hill.
8. Baron JC, Martinot JL, Cambon H, Boulenger JP, Poirier MF, Caillard V, Blin J, Huret JD, Loc'h C, Maziere B (1989) Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment : correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology (Berl) 99:463-472.
9. Bedard AM, Maheux J, Levesque D, Samaha AN (2011) Continuous, but not intermittent, antipsychotic drug delivery intensifies the pursuit of reward cues. Neuropsychopharmacology 36:1248-1259.
10. Bello EP, Mateo Y, Gelman DM, Noain D, Shin JH, Low MJ, Alvarez VA, Lovinger DM, Rubinstein M (2011) Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 14:1033-1038.
11. Brenhouse HC, Sonntag KC, Andersen SL (2008) Transient D1 dopamine receptor expression on prefrontal cortex projection neurons : relationship to enhanced motivational salience of drug cues in adolescence. J Neurosci 28:2375-2382.
12. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96.
13. Calipari ES, Huggins KN, Mathews TA, Jones SR (2012) Conserved dorsal-ventral gradient of dopamine release and uptake rate in mice, rats and rhesus macaques. Neurochem Int 60:986-991.
14. Cardinal RN, Parkinson JA, Lachenal G, Halkerston KM, Rudarakanchana N, Hall J, Morrison CH, Howes SR, Robbins TW, Everitt BJ (2002) Effects of selective excitotoxic lesions of the nucleus accumbens core, anterior cingulate cortex, and central nucleus of the amygdala on autoshaping performance in rats. Behav Neurosci 116:553-567.
15. Catlow JT, Barton RD, Clemens M, Gillespie TA, Goodwin M, Swanson SP (1995) Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 668:85-90.
16. Cheer JF, Aragona BJ, Heien ML, Seipel AT, Carelli RM, Wightman RM (2007) Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron 54:237-244.
17. Cheng-Shannon J, McGough JJ, Pataki C, McCracken JT (2004) Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 14:372-394.
18. Day JJ, Roitman MF, Wightman RM, Carelli RM (2007) Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens. Nat Neurosci 10:1020-1028.
19. Di Ciano P, Cardinal RN, Cowell RA, Little SJ, Everitt BJ (2001) Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of Pavlovian approach behavior. J Neurosci 21:9471-9477.
20. El-Nabawi A, Quesenberry M, Saito K, Silbergeld E, Vasta G, Eldefrawi A (2000) The N-methyl-D-aspartate neurotransmitter receptor is a mammalian brain target for the dinoflagellate Pfiesteria piscicida toxin. Toxicol Appl Pharmacol 169:84-93.
21. Frost DO, Cadet JL (2000) Effects of drug-induced neurotoxicity on development of neural circuitry : A hypothesis. Br Res Rev 34:103-118.
22. Gardner EL (2011) Addiction and brain reward and antireward pathways. Adv Psychosom Med 30:22-60.
23. Giedd JN, Lalonde FM, Celano MJ, White SL, Wallace GL, Lee NR, Lenroot RK (2009) Anatomical brain magnetic resonance imaging of typically developing children and adolescents. J Am Acad Child Adolesc Psychiatry 48:465-470.
24. Ginovart N, Wilson AA, Hussey D, Houle S, Kapur S (2009) D2- receptor upregulation is dependent upon temporal course of D2-occupancy: A longitudinal [11C]-raclopride PET study in cats. Neuropsychopharmacology 34:662-671.
25. Grace AA, Floresco SB, Goto Y, Lodge DJ (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30:220-227.
26. Gruber AJ, Hussain RJ, O'Donnell P (2009) The nucleus accumbens: A switchboard for goal-directed behaviors. PLoS ONE 4 :e5062.
27. Heien ML, Johnson MA, Wightman RM (2004) Resolving neurotransmitters detected by fast-scan cyclic voltammetry. Anal Chem 76:5697-5704.
28. Jones SR, O'Dell SJ, Marshall JF, Wightman RM (1996) Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain. Synapse 23:224-231.
29. Kapur S, VanderSpek SC, Brownlee BA, Nobrega JN (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition : A suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305:625-631.
30. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238.
31. Lecca D, Valentini V, Cacciapaglia F, Acquas E, Di Chiara G (2007) Reciprocal effects of response contingent and noncontingent intravenous heroin on in vivo nucleus accumbens shell vs. core dopamine in the rat : A repeated sampling microdialysis study. Psychopharmacology (Berl) 194:103-116.
32. Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH (1997) New evidence for neurotransmitter influences on brain development. Trends Neurosci 20:269-274.
33. Li Y, Acerbo MJ, Robinson TE (2004) The induction of behavioural sensitization is associated with cocaine-induced structural plasticity in the core (but not shell) of the nucleus accumbens. Eur J Neurosci 20:1647-1654.
34. Liao RM (2008) Development of conditioned place preference induced by intra-accumbens infusion of amphetamine is attenuated by co-infusion of dopamine D1 and D2 receptor antagonists. Pharmacol Biochem Behav 89:367-373.
35. Llorente-Berzal A, Mela V, Borcel E, Valero M, Lopez-Gallardo M, Viveros MP, Marco EM (2011) Neurobehavioral and metabolic long-term consequences of neonatal maternal deprivation stress and adolescent olanzapine treatment in male and female rats. Neuropharmacology 62: 1332-1341.
36. McCracken JT, Suddath R, Chang S, Thakur S, Piacentini J (2008) Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. J Child Adolesc Psychopharmacol 18:501-508.
37. McKnight RF, Park RJ (2010) Atypical antipsychotics and anorexia nervosa: A review. Eur Eat Disord Rev 18:10-21.
38. Meyer U, Spoerri E, Yee BK, Schwarz MJ, Feldon J (2010) Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull 36:607-623.
39. Morgan MA, LeDoux JE (1995) Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci 109:681-688.
40. Oberlander TF, Gingrich JA, Ansorge MS (2009) Sustained neurobehavioral effects of exposure to SSRI antidepressants during development : molecular to clinical evidence. Clin Pharmacol Ther 86:672-677.
41. Pappadopulos E, Macintyre Ii JC, Crismon ML, Findling RL, Malone RP, Derivan A, Schooler N, Sikich L, Greenhill L, Schur SB, Felton CJ, Kranzler H, Rube DM, Sverd J, Finnerty M, Ketner S, Siennick SE, Jensen PS (2003) Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry 42:145-161.
42. Pappadopulos E, Rosato NS, Correll CU, Findling RL, Lucas J, Crystal S, Jensen PS (2011) Experts' recommendations for treating maladaptive aggression in youth. J Child Adolesc Psychopharmacol 21:505-515.
43. Parkinson JA, Dalley JW, Cardinal RN, Bamford A, Fehnert B, Lachenal G, Rudarakanchana N, Halkerston KM, Robbins TW, Everitt BJ (2002) Nucleus accumbens dopamine depletion impairs both acquisition and performance of appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine function. Behav Brain Res 137:149-163.
44. Parkinson JA, Willoughby PJ, Robbins TW, Everitt BJ (2000) Disconnection of the anterior cingulate cortex and nucleus accumbens core impairs Pavlovian approach behavior: further evidence for limbic cortical-ventral striatopallidal systems. Behav Neurosci 114:42-63.
45. Perez-Costas E, Guidetti P, Melendez-Ferro M, Kelley JJ, Roberts RC (2008) Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays. J Neural Transm 115:745-753.
46. Petanjek Z, Judas M, Simic G, Rasin MR, Uylings HB, Rakic P, Kostovic I (2011) Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc Natl Acad Sci USA 108:13281-13286.
47. Peters J, Kalivas PW, Quirk GJ (2009) Extinction circuits for fear and addiction overlap in prefrontal cortex. Learn Mem 16:279-288.
48. Piontkewitz Y, Arad M, Weiner I (2011) Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr Bull 37:1257-1269.
49. Piontkewitz Y, Assaf Y, Weiner I (2009) Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol Psychiatry 66:1038-1046.
50. Remington G, Kapur S (2010) Antipsychotic dosing: how much but also how often? Schizophr Bull 36:900-903.
51. Richtand NM, Ahlbrand R, Horn P, Stanford K, Bronson SL, McNamara RK (2011) Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation. J Psychiatr Res 45:1194-1201.
52. Richtand NM, Ahlbrand R, Horn P, Tambyraja R, Grainger M, Bronson SL, McNamara RK (2012) Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response. Physiol Behav 106:171-177.
53. Richtand NM, Taylor B, Welge JA, Ahlbrand R, Ostrander MM, Burr J, Hayes S, Coolen LM, Pritchard LM, Logue A, Herman JP, McNamara RK (2006) Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions. Neuropsychopharmacology 31:77-89.
54. Samaha AN, Seeman P, Stewart J, Rajabi H, Kapur S (2007) 'Breakthrough' dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neurosci 27:2979-2986.
55. Scheltema Beduin A, de Haan L (2010) Off-label second generation antipsychotics for impulse regulation disorders : A review. Psychopharmacol Bull 43:45-81.
56. Sikich L (2008) Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders. J Clin Psychiatry 69(Suppl. 4) :21-25.
57. Silvestri S, Seeman MV, Negrete JC, Houle S, Shammi CM, Remington GJ, Kapur S, Zipursky RB, Wilson AA, Christensen BK, Seeman P (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: A clinical PET study. Psychopharmacology (Berl) 152:174-180.
58. Simpson KL, Weaver KJ, de Villers-Sidani E, Lu JY, Cai Z, Pang Y, Rodriguez-Porcel F, Paul IA, Merzenich M, Lin RC (2011) Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci USA 108:18465-18470.
59. Strawn JR, Delbello MP (2008) Olanzapine for the treatment of bipolar disorder in children and adolescents. Expert Opin Pharmacother 9 :467-474.
60. Suzuki M, Hatano K, Sakiyama Y, Kawasumi Y, Kato T, Ito K (2001) Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography. Synapse 41:285-293.
61. Tarazi FI, Zhang K, Baldessarini RJ (2001) Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain : implications for antipsychotic drug treatment. J Pharmacol Exp Ther 297:711-717.
62. Terry Jr. AV, Warner SE, Vandenhuerk L, Pillai A, Mahadik SP, Zhang G, Bartlett MG (2008) Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats. Neuroscience 156:1005-1016.
63. Thomas T, Stansifer L, Findling RL (2011) Psychopharmacology of pediatric bipolar disorders in children and adolescents. Pediatr Clin North Am 58:173-187, xii.
64. Uylings HBM, Groenewegen HJ, Kolb B (2003) Do rats have a prefrontal cortex? Behav Brain Res 146:3-17.
65. Vasconcelos SM, Nascimento VS, Nogueira CR, Vieira CM, Sousa FC, Fonteles MM, Viana GS (2003) Effects of haloperidol on rat behavior and density of dopaminergic D2-like receptors. Behav Processes 63:45-52.
66. Vidal-Infer A, Roger-Sanchez C, Daza-Losada M, Aguilar MA, Minarro J, Rodriguez-AriasM(2012) Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-Induced conditioned place preference in adolescent mice. PLoS ONE 7:e43107.
67. Wahlstrom D, White T, Luciana M (2010) Neurobehavioral evidence for changes in dopamine system activity during adolescence. Neurosc Biobehav Rev 34:631-648.
68. Weller EB, Weller RA (2009) Olanzapine as treatment for children and adolescents with Tourette's syndrome. Curr Psychiatry Rep 11:95-96.
69. Wightman RM, Heien ML, Wassum KM, Sombers LA, Aragona BJ, Khan AS, Ariansen JL, Cheer JF, Phillips PE, Carelli RM (2007) Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur J Neurosci 26:2046-2054.
70. Willuhn I, Wanat MJ, Clark JJ, Phillips PE (2010) Dopamine signaling in the nucleus accumbens of animals selfadministering drugs of abuse. Curr Top Behav Neurosci 3 :29-71.
71. Yadav PN, Abbas AI, Farrell MS, Setola V, Sciaky N, Huang XP, Kroeze WK, Crawford LK, Piel DA, Keiser MJ, Irwin JJ, Shoichet BK, Deneris ES, Gingrich J, Beck SG, Roth BL (2011) The presynaptic component of the serotonergic system is required for clozapine's efficacy. Neuropsychopharmacology 36:638-651.
72. Zuddas A, Zanni R, Usala T (2011) Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents : A review of the randomized controlled studies. Eur Neuropsychopharmacol 21:600-620.